| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LIFW | Class A Common Stock | Sale | $38,118 | -24,914 | -0.32% | $1.53 | 7,809,039 | 11 Jan 2024 | See Footnote | F1, F2 |
| transaction | LIFW | Class A Common Stock | Sale | $45,253 | -29,969 | -0.38% | $1.51 | 7,779,070 | 12 Jan 2024 | See Footnote | F2, F3 |
| transaction | LIFW | Class A Common Stock | Sale | $6,571 | -5,016 | -0.06% | $1.31 | 7,774,054 | 16 Jan 2024 | See Footnote | F2, F4 |
| Id | Content |
|---|---|
| F1 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.50 to $1.68. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. |
| F3 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.48 to $1.55. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.30 to $1.40. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |